Holen Sie sich die Stockscreener-App
5.25
0.48%
0.02
Schlusskurs vom Vortag:
$5.23
Offen:
$5.25
24-Stunden-Volumen:
540.98K
Relative Volume:
0.78
Marktkapitalisierung:
$316.16M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-44.80M
KGV:
-7.00
EPS:
-0.75
Netto-Cashflow:
$-30.67M
1W Leistung:
+7.03%
1M Leistung:
+0.29%
6M Leistung:
+136.71%
1J Leistung:
+5.73%
1-Tages-Spanne:
$5.175
$5.345
1-Wochen-Bereich:
$4.695
$5.345
52-Wochen-Spanne:
$1.14
$7.20
Aldeyra Therapeutics Inc Stock (ALDX) Company Profile
Firmenname
Aldeyra Therapeutics Inc
Sektor
Branche
Telefon
781-761-4904
Adresse
131 HARTWELL AVENUE, LEXINGTON, MA
Vergleichen Sie ALDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics Inc
|
5.255 | 314.65M | 0 | -44.80M | -30.67M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
428.01 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.78 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.10 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.88 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.18 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-03 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-04-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-02-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-12-16 | Eingeleitet | Berenberg | Buy |
| 2020-10-30 | Eingeleitet | Jefferies | Buy |
| 2020-10-16 | Eingeleitet | BTIG Research | Buy |
| 2020-09-22 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-05-12 | Eingeleitet | Oppenheimer | Outperform |
| 2018-12-04 | Eingeleitet | Citigroup | Buy |
| 2018-09-26 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Eingeleitet | Janney | Buy |
| 2018-01-26 | Eingeleitet | Seaport Global Securities | Buy |
| 2016-09-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-07-01 | Eingeleitet | Stifel | Buy |
| 2015-07-01 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-03-25 | Eingeleitet | Chardan Capital Markets | Buy |
| 2015-03-20 | Bestätigt | H.C. Wainwright | Buy |
| 2014-11-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2014-06-19 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Aldeyra Therapeutics Inc Aktie (ALDX) Neueste Nachrichten
Why retail investors favor Aldeyra Therapeutics Inc. stock2025 Short Interest & Free Growth Oriented Trading Recommendations - newser.com
Aldeyra Therapeutics Inc Stock Analysis and ForecastContrarian Investment Ideas & Small Investment Trading Tips - earlytimes.in
What sentiment indicators say about Aldeyra Therapeutics Inc. stockJuly 2025 News Drivers & AI Based Buy/Sell Signal Reports - newser.com
Intraday pattern recognizer results for Aldeyra Therapeutics Inc.July 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Aldeyra Therapeutics Inc. stock daily chart insightsTrend Reversal & AI Forecast Swing Trade Picks - newser.com
Understanding Aldeyra Therapeutics Inc.’s price movement - newser.com
Live market analysis of Aldeyra Therapeutics Inc.CEO Change & Short-Term High Return Ideas - newser.com
How Aldeyra Therapeutics Inc. stock performs in weak economyGap Down & Weekly Market Pulse Alerts - newser.com
Why Aldeyra Therapeutics Inc. stock is in analyst buy zonePortfolio Update Summary & High Conviction Buy Zone Alerts - newser.com
Can a trend reversal in Aldeyra Therapeutics Inc. lead to recoveryPortfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
Applying Wyckoff theory to Aldeyra Therapeutics Inc. stock2025 Market Trends & Daily Growth Stock Investment Tips - newser.com
What candlestick patterns are forming on Aldeyra Therapeutics Inc.Market Growth Report & Risk Managed Trade Strategies - newser.com
Aldeyra Therapeutics Inc.’s volatility index tracking explainedMarket Performance Recap & Real-Time Volume Surge Alerts - newser.com
Aldeyra Therapeutics, Inc. (ALDX) Discusses Expansion of RASP Platform Into CNS Diseases and Update on Reproxalap for Dry EyeSlideshow (NASDAQ:ALDX) 2025-11-16 - Seeking Alpha
Sentiment analysis tools applied to Aldeyra Therapeutics Inc.July 2025 Recap & Weekly Market Pulse Alerts - newser.com
Smart tools for monitoring Aldeyra Therapeutics Inc.’s price actionWeekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
What to expect from Aldeyra Therapeutics Inc. in the next 30 daysTrade Ideas & Weekly Top Gainers Trade List - newser.com
How Aldeyra Therapeutics Inc. stock responds to policy changes2025 Technical Patterns & Expert Approved Trade Ideas - Fundação Cultural do Pará
Is Aldeyra Therapeutics Inc. stock resilient to inflation2025 Market Sentiment & Accurate Intraday Trade Tips - Fundação Cultural do Pará
Is Aldeyra Therapeutics Inc. stock dividend yield sustainableQuarterly Market Summary & Pattern Based Trade Signal System - Fundação Cultural do Pará
Finanzdaten der Aldeyra Therapeutics Inc-Aktie (ALDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):